|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Products | |||||
| Services and other | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Products | |||||
| Services and other | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Goodwill impairment | |||||
| Operating income (loss) | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on partial extinguishment of debt | |||||
| Other non-operating income | |||||
| Loss before income taxes and income from equity method investees | |||||
| Income tax expense (benefit) | |||||
| Income from equity method investees | |||||
| Consolidated net income (loss) | |||||
| Net loss attributable to noncontrolling interest | |||||
| Net income (loss) attributable to Class A and B-1 common stockholders | |||||
| Net income (loss) per Class A and B-1 common share: | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average shares used in computing net income (loss) per Class A and B-1 common share: | |||||
| Basic | |||||
| Diluted |
Loading...